Rathbones Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.2M Buy
285,836
+57,850
+25% +$5.06M 0.1% 119
2026
Q1
$19.4M Buy
227,986
+13,470
+6% +$1.2M 0.08% 126
2025
Q4
$17M Buy
214,516
+38,939
+22% +$3.05M 0.07% 139
2025
Q3
$14M Sell
175,577
-23,939
-12% -$2.04M 0.06% 144
2025
Q2
$18.1M Sell
199,516
-15,140
-7% -$1.38M 0.08% 132
2025
Q1
$20.1M Sell
214,656
-11,645
-5% -$1.04M 0.1% 125
2024
Q4
$20.6M Sell
226,301
-26,919
-11% -$2.57M 0.1% 124
2024
Q3
$26.3M Sell
253,220
-18,042
-7% -$1.84M 0.13% 115
2024
Q2
$26.3M Sell
271,262
-9,534
-3% -$879K 0.14% 108
2024
Q1
$25.3M Sell
280,796
-19,862
-7% -$1.68M 0.15% 109
2023
Q4
$24M Sell
300,658
-4,541
-1% -$341K 0.15% 109
2023
Q3
$21.7M Buy
305,199
+96,770
+46% +$7.24M 0.16% 113
2023
Q2
$16.1M Buy
208,429
+8,957
+4% +$693K 0.15% 112
2023
Q1
$15M Sell
199,472
-12,334
-6% -$917K 0.15% 113
2022
Q4
$16.7M Sell
211,806
-6,523
-3% -$489K 0.19% 107
2022
Q3
$15.3M Sell
218,329
-3,834
-2% -$301K 0.19% 104
2022
Q2
$17.8M Sell
222,163
-8,381
-4% -$655K 0.2% 104
2022
Q1
$17.5M Sell
230,544
-3,723
-2% -$295K 0.18% 107
2021
Q4
$20M Sell
234,267
-26,932
-10% -$2.1M 0.19% 100
2021
Q3
$19.7M Buy
261,199
+358
+0.1% +$28.4K 0.21% 99
2021
Q2
$21.2M Sell
260,841
-3,950
-1% -$323K 0.24% 93
2021
Q1
$20.9M Buy
264,791
+9,468
+4% +$742K 0.27% 88
2020
Q4
$21.8M Sell
255,323
-26,144
-9% -$2.16M 0.31% 77
2020
Q3
$21.7M Sell
281,467
-9,015
-3% -$687K 0.37% 68
2020
Q2
$21.3M Buy
290,482
+8,413
+3% +$598K 0.43% 58
2020
Q1
$18.7M Sell
282,069
-49,780
-15% -$3.51M 0.55% 53
2019
Q4
$22.8M Buy
331,849
+1,502
+0.5% +$102K 0.6% 51
2019
Q3
$24.3M Buy
330,347
+137,280
+71% +$9.96M 0.69% 52
2019
Q2
$13.8M Sell
193,067
-2,263
-1% -$161K 0.43% 65
2019
Q1
$13.4M Sell
195,330
-15,293
-7% -$988K 0.44% 64
2018
Q4
$12.5M Sell
210,623
-55,410
-21% -$3.47M 0.48% 60
2018
Q3
$17.8M Sell
266,033
-18,011
-6% -$1.2M 0.61% 50
2018
Q2
$18.4M Sell
284,044
-98,520
-26% -$6.44M 0.7% 46
2018
Q1
$27.4M Sell
382,564
-7,453
-2% -$536K 1.12% 34
2017
Q4
$29.4M Sell
390,017
-3,191
-0.8% -$233K 1.2% 28
2017
Q3
$28.6M Buy
393,208
+24,544
+7% +$1.77M 1.25% 26
2017
Q2
$27.3M Buy
368,664
+22,105
+6% +$1.64M 1.22% 27
2017
Q1
$25.4M Buy
346,559
+80,226
+30% +$5.62M 1.16% 29
2016
Q4
$17.4M Buy
266,333
+33,018
+14% +$2.26M 0.87% 40
2016
Q3
$17.3M Sell
233,315
-2,277
-1% -$168K 0.89% 40
2016
Q2
$17.2M Sell
235,592
-1,405
-0.6% -$100K 0.95% 36
2016
Q1
$16.7M Buy
236,997
+2,845
+1% +$189K 1.02% 34
2015
Q4
$14.9M Buy
234,152
+1,888
+0.8% +$126K 0.94% 36
2015
Q3
$14.7M Sell
232,264
-2,740
-1% -$179K 0.98% 36
2015
Q2
$15.4M Sell
235,004
-5,510
-2% -$374K 1% 33
2015
Q1
$16.7M Sell
240,514
-13,684
-5% -$946K 1.1% 30
2014
Q4
$17.6M Buy
254,198
+19,779
+8% +$1.34M 1.16% 25
2014
Q3
$15.3M Buy
234,419
+14,885
+7% +$982K 1.06% 29
2014
Q2
$15M Sell
219,534
-1,006
-0.5% -$67.4K 1.06% 31
2014
Q1
$14.3M Sell
220,540
-1,788
-0.8% -$113K 1.15% 21
2013
Q4
$14.5M Sell
222,328
-770
-0.3% -$49.3K 1.45% 17
2013
Q3
$13.2M Sell
223,098
-1,829
-0.8% -$108K 1.54% 14
2013
Q2
$12.9M Buy
+224,927
New +$13.4M 1.74% 14

Other funds holding CL

Rathbones Group's CL Position: Q2 2026 in Review

Rathbones Group increased its Colgate-Palmolive (CL) stake by 25% in Q2 2026, buying an estimated $5.06M and bringing the position to 285,836 shares worth $26.2M. The position accounts for 0.1% of the portfolio, ranked #119.

Rathbones Group first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $29.4M in Q4 2017. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Rathbones Group held 285,836 shares of Colgate-Palmolive worth $26.2M as of Q2 2026.
  • Rathbones Group bought 57,850 Colgate-Palmolive shares in Q2 2026, an estimated $5.06M.
  • Colgate-Palmolive made up 0.1% of Rathbones Group's portfolio in Q2 2026, its #119 holding.
  • Rathbones Group first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Rathbones Group's Colgate-Palmolive position peaked at $29.4M in Q4 2017.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.